Results 1 to 10 of about 7,983,647 (299)

Pathological Response Patterns to Preoperative Chemoradiation and the Factors Determining Pathological Complete Response in Locally Advanced Carcinoma Rectum

Indian Journal of Colo-Rectal Surgery
Background: Rectal cancer is a formidable health problem worldwide. It is the third most common cancer in men (663,000 cases, 10.0% of all cancer cases) and the second most common in women (571,000 cases, 9.4% of all cancer cases). Rectal cancer accounts
S. Subbiah Shanmugam, Aravind Shivakumar
doaj   +1 more source

Local tuning of radiomics-based model for predicting pathological response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer

BMC Medical Imaging, 2022
Purpose This study aims to further enhance a validated radiomics-based model for predicting pathologic complete response (pCR) after chemo‑radiotherapy in locally advanced rectal cancer (LARC) for use in clinical practice.
Bin Tang, Jacopo Lenkowicz, Qian Peng, Luca Boldrini, Qing Hou, Nicola Dinapoli, Vincenzo Valentini, Peng Diao, Gang Yin, Lucia Clara Orlandini   +9 more
doaj   +1 more source

A cfDNA fragmentomics-based machine learning model for predicting treatment response and recurrence in locally advanced rectal cancer after neoadjuvant chemoradiotherapy

The Journal of Liquid Biopsy
Neoadjuvant chemoradiotherapy (nCRT) is standard treatment for locally advanced rectal cancer (LARC), but responses vary substantially. We developed Fragmentia-AI Response, a machine learning model that uses cell-free DNA (cfDNA) fragment features to ...
Kun Miao, Song Wang, Guofeng Sun, Hua Bao, Yang Shao, Zhijun Zeng   +5 more
doaj   +1 more source

Encouraging Pathological Complete Response Rate from Neoadjuvant Chemotherapy with Albumin-Bound Paclitaxel Plus Cisplatin and Capecitabine for Locally Advanced Esophageal Squamous Carcinoma: Preliminary Outcome of a Retrospective Study

Cancer Management and Research, 2021
Wen Zhang,1,* Yong Li,2,* Liyan Xue,3 Dong Qu,4 Zhichao Jiang,1 Zhen Wang,2 Zhaoyang Yang,3 Aiping Zhou1 1Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical ...
Zhang W, Li Y, Xue L, Qu D, Jiang Z, Wang Z, Yang Z, Zhou A   +7 more
doaj  

Hepatectomy After Conversion Therapy with Hepatic Arterial Infusion Chemotherapy, Tyrosine Kinase Inhibitors and Anti-PD-1 Antibodies for Initially Unresectable Hepatocellular Carcinoma

Journal of Hepatocellular Carcinoma, 2023
Bingran Yu, Ning Zhang, Yun Feng, Yongfa Zhang, Ti Zhang, Lu Wang Department of Hepatic Surgery, Shanghai Cancer Center, Shanghai Medical College, Fudan University, Shanghai, People’s Republic of ChinaCorrespondence: Lu Wang, Department of Hepatic ...
Yu B, Zhang N, Feng Y, Zhang Y, Zhang T, Wang L   +5 more
doaj  

Pathological complete response following neoadjuvant chemotherapy for locally advanced intrahepatic cholangiocarcinoma

Surgical Case Reports
Background Intrahepatic cholangiocarcinoma (ICC) is the second most common primary liver cancer. Cases when found are often advanced with vascular invasion, and radical resection is often difficult.
Yoshitaka Shimamaki, Isamu Hosokawa, Tsukasa Takayashiki, Shigetsugu Takano, Itaru Sonoda, Masayuki Ohtsuka   +5 more
doaj   +1 more source

Pathological Complete Response with Neoadjuvant Trastuzumab Combined with Chemotherapy in HER2 Positive Breast Cancer: A Single Institution Retrospective Analysis from Vietnam

Breast Cancer: Targets and Therapy, 2020
Huyen Thi Phung,1 Hoa Thi Nguyen,1 Tung Van Nguyen,1 Tai Van Nguyen,2 Lan Anh Thi Dinh,3 Chu Van Nguyen4 1Department of Medical Oncology 6, National Cancer Hospital of Vietnam, Hanoi, Vietnam; 2Department of Medical Oncology 1, National Cancer Hospital ...
Phung HT, Thi Nguyen H, Nguyen TV, Nguyen TV, Dinh LAT, Nguyen CV   +5 more
doaj  

Deep learning-based predictive model for pathological complete response to neoadjuvant chemotherapy in breast cancer from biopsy pathological images: a multicenter study

Frontiers in Physiology
Introduction: Early predictive pathological complete response (pCR) is beneficial for optimizing neoadjuvant chemotherapy (NAC) strategies for breast cancer.
Huancheng Zeng, Siqi Qiu, Siqi Qiu, Shuxin Zhuang, Xiaolong Wei, Jundong Wu, Ranze Zhang, Kai Chen, Zhiyong Wu, Zhemin Zhuang   +9 more
doaj   +1 more source

Factors Affecting Pathological Complete Response in Locally Advanced Breast Cancer Cases Receiving Neoadjuvant Therapy: A Comprehensive Literature Review

European Journal of Breast Health
Determining pathological complete response (pCR) could be an important step in planning individual treatment, hence improving the prognosis in terms of survival. Achieving breast pCR not only improves survival but is also linked to a disease-free axilla,
Munaser Alamoodi
doaj   +1 more source

Favorable short-term survival in locally advanced cervical cancer with optimal pathological response after neoadjuvant chemoimmunotherapy: a real-world analysis

Frontiers in Immunology
BackgroundThis real-world study evaluated short-term survival outcomes and potential risk factors in patients with locally advanced cervical cancer (LACC) who achieved optimal pathological response (OPR) following neoadjuvant chemoimmunotherapy and ...
Luyang Zhao, Qingzhi Zhai, Wenbo Zhang, Liang Wen, Xiaoyu Fu, Xiufeng Xie, Xiangshu Jin, Nina Zhang, Yuanguang Meng, Li’an Li, Chenglei Gu   +10 more
doaj   +1 more source